阿雷丘因A-D,是来自Areca catechu皮的阿雷科林化物L
Biao Sun1, Yuanning Wu1, Jianzhan Yang2
1Guangdong Provincial Engineering Research Center for Modernization of TCM, NMPA Key Laboratory for Quality Evaluation of TCM, College of Pharmacy, Jinan University, Guangzhou, China.
Natural product research
|January 29, 2025
概括
从Areca catechu的皮肤中分离出了四种新的阿雷科林类类类体. 化合物3在谷氨酸诱导的细胞中显示出显著的神经保护作用.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝特尔坚果 (Areca catechu L.) 是生物活性类化合物的来源.
- 阿拉科林类化合物以各种药理学活动而闻名.
- 来自自然来源的类化合物中的亚tropisomerism是罕见的.
研究的目的:
- 从Areca catechu皮皮中分离和鉴定新型的阿雷科林类类类基体.
- 评估分离化合物的神经保护潜力.
主要方法:
- 使用色谱技术分离化合物.
- 使用UV,IR,MS和NMR光谱学的结构阐明.
- 通过实验和计算的电子循环二元化 (ECD) 光谱来确定绝对配置.
- 在谷氨酸诱导的HT22细胞损伤模型中评估神经保护作用.
主要成果:
- 成功分离了四种新型的阿雷科林类化物基体,被指定为阿雷丘因A-D (1-4).
- 确定了化合物1-4的结构和绝对配置.
- 化合物3在10μM度下表现出强大的神经保护作用.
结论:
- 这项研究报告了第一次从Areca catechu中分离了阿雷科林类类体的基体.
- 阿雷丘因D代表了一种新型的阿雷丘林类类基体.
- 化合物3显示出有前途的神经保护作用,需要进一步研究.
相关概念视频
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
850
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
850
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
676
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
676
Physical Properties of Amines
3.0K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
Adrenergic Agonists: Mixed-Action Agents
657
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
657


